Pfizer, Inc.

Pfizer Agrees to Take Over Metsera for $4.9 Billion

Pfizer to acquire Metsera, a New York, NY-based clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases.